News
At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...
The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.
Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...
18h
MedPage Today on MSNPhototherapy Promising as Add-On to Oral Ritlecitinib for VitiligoAdding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in ...
15h
MedPage Today on MSNAppendectomy Reduced Relapse Rates in Ulcerative ColitisAppendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...
During a live event, Chris Benton, MD, discussed the focus on anemia management, reducing transfusions, and improving quality of life in MDS.
The United States should avoid imposing tariffs on pharmaceutical imports, as such measures would disrupt global medical supply chains, drive up healthcare costs for American consumers, and undermine ...
GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...
In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...
U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...
Abu Dhabi, United Arab Emirates – A groundbreaking ‘Declaration on Longevity and Precision Medicine’ was launched at Abu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results